Author:
Evans Christopher H.,Ghivizzani Steven C.,Robbins Paul D.
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. US Food and Drug Administration. Approved cellular and gene therapy products. US Food and Drug Administration. FDA
https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/default.htm
(2018).
2. Evans, C. H., Ghivizzani, S. C. & Robbins, P. D. Gene delivery to joints by intra-articular injection. Hum. Gene Ther. 29, 2–14 (2018).
3. Watson, R. S. et al. scAAV-mediated gene transfer of interleukin-1 receptor antagonist to synovium and articular cartilage in large mammalian joints. Gene Ther. 20, 670–677 (2013).
4. Ruan, M. Z. et al. Proteoglycan 4 expression protects against the development of osteoarthritis. Sci. Transl Med. 5, 176ra134 (2013).
5. Kim, M. K. et al. A multicenter, double-blind, phase III clinical trial to evaluate the efficacy and safety of a cell and gene therapy in knee osteoarthritis patients. Hum. Gene Ther. Clin. Dev.
https://doi.org/10.1089/hum.2017.249
(2018).
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献